Connecticut medical informatics startup AdhereTx Corp. has scored $150,000 from the pre-seed fund of the state’s quasi-public tech investment and development agency, Connecticut Innovations (CI).

The company has developed KnowMyMeds, a secure web-based software platform to help manage and automate complex medication regimens in older adults. The platform generates a SmartList, listing medications and possible patient risks. Health-care providers can use KnowMyMeds to gather self-reported medical information and structure the data. 

AdhereTx has exclusively licensed its technology from the University of Connecticut. The company previously was located in Cambridge before its recent move to the Connecticut Center for Advanced Technology incubator in East Hartford, Conn.

CI’s pre-seed fund amounts to $4 million that the agency can distribute through loans of up to $150,000. The funding is designed to help build Connecticut startups by providing for the costs associated with new hires, intellectual property development, business plan development, market analyses, technology assessments, market entry strategy development, accounting or legal support.

AdhereTx was co-founded in 2009 by CEO Patricia Meisner and CTO Anne Marie Biernacki, a Mass High Tech Women to Watch honoree in 2005.